Form 4 for RGEN REPLIGEN CORP
Accepted 2026-07-17 16:40:41 ET · period of report 2026-07-16 · accession 0001193125-26-307925 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-17 16:40 | 2026-07-16 | RGEN | Garland Jason K | CFO | S - Sale | $150.00 | -530 | 18.8K | -3% | -$79.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-16 | S | D | 530 | $150.00 | 18,829 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025. |